(Q61975423)
Statements
A Randomized Phase II Study to Evaluate the Efficacy and Safety of Chemotherapy (CT) vs Androgen Deprivation Therapy (ADT) in Patients With Recurrent and/or Metastatic, Androgen Receptor (AR) Expressing, Salivary Gland Cancer (SGCs) (English)
0 references
February 2015
0 references
June 2021
0 references
152
0 references
18 year
0 references